$10,000 in Rocket Lab at Its Record High Is Worth About $3,900 Today. Here's What Gets That Money Back.

Source The Motley Fool

Key Points

  • Rocket Lab stock is down roughly 61% from the lifetime high it reached in May.

  • The company will need to continue posting strong sales growth in order for its stock to bounce back.

  • Rocket Lab stock may also need interest in space stocks to rebound in order to power a rebound for its stock.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

Rocket Lab (NASDAQ: RKLB) has solidified its position as a credible and reliable provider of launch services to place payloads into Earth orbit. The company trails behind only Space Exploration Technologies in the category.

Rocket Lab's strong sales growth has translated into huge valuation gains since it went public through a merger with a special purpose acquisition company (SPAC) in August 2021. The company's share price is up roughly 459% since its public debut. On the other hand, Rocket Lab is also currently down big from its valuation peak.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

A rocket launching.

Image source: Getty Images.

Rocket Lab stock hit a lifetime high of roughly $150 per share late in May of this year. As of this writing, the stock is down roughly 61% from its peak. That means a $10,000 investment made at the height of the company's valuation surge would now be worth just $3,900.

What would it take for Rocket Lab to bounce back and reclaim its valuation?

Rocket Lab stock needs more contract wins and renewed industry momentum

While Rocket Lab stock has seen valuation drawdowns this year, the company has generally continued to post encouraging business performance. In the second quarter, the company grew its revenue 62% year over year to reach roughly $234 million. Meanwhile, Rocket Lab's order backlog grew to $2.36 billion -- up 137% year over year compared to where it stood at the end of the prior-year period.

On the other hand, the business has faced some material setbacks. The launch of the company's next-generation Neutron rocket was originally scheduled for this year, but it has now been pushed to 2027. The introduction of Neutron represents a meaningful step in scaling up Rocket Lab's operations and improving margins, and the delay has prompted investors to adopt a more cautious approach to the stock. Successfully introducing Neutron early next year could help reinvigorate bullish momentum for Rocket Lab stock.

RKLB PS Ratio (Forward) Chart

RKLB PS Ratio (Forward) data by YCharts

Rocket Lab has seen a substantial valuation pullback, and it's now valued at roughly 36 times this year's expected sales. That's still a heavily growth-dependent valuation, but it represents a huge multiple contraction relative to where the stock traded at its peak. When it comes to performance for space stocks over the last half year, this type of multiple contraction isn't unique to Rocket Lab.

Space stocks saw big valuation run-ups in the lead-up to the initial public offering of Space Exploration Technologies, but other stocks in the category have seen big multiple compressions following SpaceX's public debut. In general, bullish momentum for growth stocks has been heavily concentrated around artificial intelligence (AI) plays in the subsequent months -- and space stocks without strong AI stories have been punished.

So, in addition to posting stronger business results, Rocket Lab may need the market to reinvigorate interest in the broader space stock category to reclaim its previous valuation highs.

Missed AI’s "Act 1"? Act 2 Could Be 14x Bigger

Most investors think they missed the AI boat because they didn't buy Nvidia in 2005.

But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout, a massive technology build-out that Google’s CEO says could be more profound than fire or electricity.

While everyone watches the chip designers, one "backbone" company provides the critical technology that Nvidia and AMD literally cannot function without. We’ve detailed this under-the-radar player in our new AI Playbook.

Continue »

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Anthropic files for a $2 trillion IPO — the $80.7 billion loss is the decoy, the $450 billion compute bill is the riskAnthropic publicly filed its S-1 on October 26, revealing $16.29 billion of first-half revenue (+1,304% year over year) and a $80.7 billion net loss — of which $72.4 billion is a non-cash convertible-note charge. The real number is the $450 billion of signed, mostly non-cancelable compute commitments. Here is what the filing says, why NVDA, ARM and MU are the tradeable read-through, and the conditions that decide whether the AI trade passes its first public valuation test.
Author  Irene Q.
Oct 27, Tue
Anthropic publicly filed its S-1 on October 26, revealing $16.29 billion of first-half revenue (+1,304% year over year) and a $80.7 billion net loss — of which $72.4 billion is a non-cash convertible-note charge. The real number is the $450 billion of signed, mostly non-cancelable compute commitments. Here is what the filing says, why NVDA, ARM and MU are the tradeable read-through, and the conditions that decide whether the AI trade passes its first public valuation test.
placeholder
Brent's $115 front month sits $4.6 above January — the $14 spread to WTI is the supply-risk premiumDecember Brent trades at $115.29 while January is $110.71, a $4.58 backwardation. The December Brent-WTI spread is $14.2, versus a $3-5 normal. That gap, not the headline, is where the Middle East supply risk is priced. Here is what the curve says, why the December contract's expiry on October 30 will mechanically cut the headline by $4.6, and the 108.81 neckline that decides the next move.
Author  Irene Q.
Oct 28, Wed
December Brent trades at $115.29 while January is $110.71, a $4.58 backwardation. The December Brent-WTI spread is $14.2, versus a $3-5 normal. That gap, not the headline, is where the Middle East supply risk is priced. Here is what the curve says, why the December contract's expiry on October 30 will mechanically cut the headline by $4.6, and the 108.81 neckline that decides the next move.
placeholder
The Fed held at 3.75%–4.00% — and two officials voted to hike. December is now 85% pricedThe FOMC held by a 10–2 vote, with Governor Cook and Cleveland Fed President Hammack dissenting for a 25bp hike. Chair Warsh offered no forward guidance and no dot plot, the 2-year yield fell 8bp to 4.70%, and the dollar slipped to 101.84 even as markets moved December hike odds to 85%–87%. Tonight's Q3 GDP and September core PCE are the next referee.
Author  Irene Q.
Oct 29, Thu
The FOMC held by a 10–2 vote, with Governor Cook and Cleveland Fed President Hammack dissenting for a 25bp hike. Chair Warsh offered no forward guidance and no dot plot, the 2-year yield fell 8bp to 4.70%, and the dollar slipped to 101.84 even as markets moved December hike odds to 85%–87%. Tonight's Q3 GDP and September core PCE are the next referee.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - October 30, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for October 30, 2026. Read on for the details.
Author  Mitrade
Oct 30, Fri
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for October 30, 2026. Read on for the details.
placeholder
US GDP grew 3.4% and core PCE held at 3.1% — December is now a hike trade, not a cut tradeUS Q3 GDP rose 3.4%, above the 3.1% estimate, while September headline PCE hit 3.6% and core held at 3.1%. December hike odds are near 90%; inventories, AI capex and energy explain why.
Author  Irene Q.
Oct 30, Fri
US Q3 GDP rose 3.4%, above the 3.1% estimate, while September headline PCE hit 3.6% and core held at 3.1%. December hike odds are near 90%; inventories, AI capex and energy explain why.
goTop
quote